Amniotic Membrane Market - By Product (Cryopreserved, Lyophilized), Application (Surgical Wounds, Ophthalmology, Stem Cell Biology, Regenerative Medicine, Prenatal Diagnosis), End-use (Hospitals, Specialty Clinics) – Global Forecast, 2024 – 2032

Amniotic Membrane Market - By Product (Cryopreserved, Lyophilized), Application (Surgical Wounds, Ophthalmology, Stem Cell Biology, Regenerative Medicine, Prenatal Diagnosis), End-use (Hospitals, Specialty Clinics) – Global Forecast, 2024 – 2032

Amniotic Membrane Market Size

Amniotic Membrane Market size was valued at over USD 1.6 billion in 2023 and is anticipated to register 11.2% CAGR between 2024 and 2032, due to increasing usage in the treatment of chronic wounds.
 

Amniotic membranes play a key role in promoting healing by reducing inflammation for providing essential growth factors and supporting cellular regeneration. Multiple medical teams are applying these membranes to various chronic wounds like diabetic ulcers and burns. Researchers are also continuing to explore new applications and delivery methods to enhance their effectiveness. As technology is advancing, the use of amniotic membranes in wound care will grow for potentially offering more efficient and accelerated healing options for chronic wound patients.
 

As per reports, in the U.S., about 2 million people annually develop diabetic foot ulcers, with over 50% dying and 5% undergoing limb amputation within five years. Amniotic membranes are used to treat these ulcers while enhancing healing and reducing complications, thus improving patient outcomes and potentially lowering mortality and amputation rate.
 

The rising geriatric population is further driving the market growth as more elderly individuals are developing chronic wounds and age-related conditions. Healthcare providers are utilizing these membranes to treat wounds as they offer regenerative properties and promote faster healing. Medical professionals are also relying on amniotic membranes to manage complex wounds effectively and improve outcomes for older patients for supporting their overall well-being. For instance, in October 2022, WHO reported that by 2030, 1 in 6 people globally will be over 60 years of age, rising from 1 billion in 2020 to 1.4 billion. The increasing elderly population will boost the demand for amniotic membrane products to address age-related wound care needs.
 

However, the high cost of amniotic membrane products and limited awareness among healthcare providers are restraining their widespread adoption. Hospitals and clinics are finding it challenging to integrate these products due to budget constraints and knowledge gaps. These issues may continue to limit the market expansion, as both cost and educational barriers will be posing significant challenges to broader usage in medical treatments.
 

Amniotic Membrane Market Trends

Increasing investments in R&D are driving the creation of new applications and improved formulations of amniotic membranes. Companies and researchers are exploring innovative ways to enhance their therapeutic benefits, leading to novel products for wound care and surgical applications. This trend is fostering the market growth for generating advanced treatments that better support healing. The ongoing R&D efforts will continue to produce cutting-edge amniotic membrane products for expanding their use in various medical fields. These advancements will be contributing to more effective and versatile therapies, further strengthening their role in healthcare.
 

Furthermore, amniotic membranes are being increasingly utilized in regenerative medicine due to their anti-inflammatory, anti-fibrotic, and anti-microbial properties. They help in enhancing wound healing and tissue engineering applications. Rising advancements to drive their demand and expand their use in more regenerative therapies for contributing to improved patient outcomes will favor the market growth.
 

Amniotic Membrane Market Analysis

Based on product, the cryopreserved segment is projected to exceed USD 2.7 billion by 2032. The growth can be ascribed to the higher utilization of cryopreserved amniotic membranes in various medical treatments due to their preserved biological properties. They help maintain essential growth factors as well as anti-inflammatory, and anti-microbial benefits for making them effective in wound healing, ophthalmology, and tissue regeneration. Clinicians are applying cryopreserved membranes to treat chronic wounds and surgical sites for their enhanced healing potential. Moreover, advancements in cryopreservation techniques will continue to improve the quality and efficacy of these membranes.
 

In terms of application, the surgical wounds segment of the amniotic membrane industry is expected to record USD 959 million by 2032, due to their strong assistance to promote faster and more effective healing. Surgeons are increasingly utilizing these membranes as a biological scaffold to enhance tissue repair and reduce scarring. The anti-inflammatory and growth-promoting properties of amniotic membranes are aiding in the recovery process for patients undergoing various surgical procedures. Subsequently, their use in surgical wounds will continue to evolve, with ongoing research focusing on optimizing application techniques and exploring additional benefits for improving post-operative outcomes and patient satisfaction.
 

On the basis of end-use, the amniotic membrane market size from the hospitals segment is predicted to record 11.8% CAGR through 2032. This surge is driven by rising incorporation of amniotic membranes for various treatments, such as to accelerate wound healing, reduce inflammation, and enhance tissue repair. Medical teams are applying them in surgeries, burns, and ulcers for leveraging their regenerative properties. Moreover, hospitals are also increasingly integrating amniotic membranes into more sophisticated regenerative therapies to improve recovery for patients with chronic wounds and injuries.

 

North America amniotic membrane market is predicted to record more than USD 1.6 billion by 2032. The presence of favorable reimbursement policies is driving increased adoption in various medical specialties. Particularly, expanding applications in ophthalmology are observed in the region, with ophthalmologists integrating amniotic membranes into treatments for conditions like corneal ulcers and surface disorders. This trend is enhancing patient care and outcomes. The ongoing advancements in ophthalmic applications will further solidify the position of amniotic membranes as a valuable therapeutic option for eye care professionals in North America.
 

Amniotic Membrane Market Share

Leading industry players actively involved in the amniotic membrane industry include biotechnology companies, medical device manufacturers, and regenerative medicine firms. These firms are continuously investing in R&D activities to innovate new products and therapies. They are also emphasizing partnership strategies to widen their global presence.
 

Amniotic Membrane Market Companies

• Alliqua BioMedical Inc.
• Alynx, Co.
• Amnio Technology, LLC
• Applied Biologics LLC
• BioTissue Holdings Inc.
•  Corza Health, Inc.
• Integra LifeSciences Corporation
• Organogensis, Inc.
• Skye Biologics, Inc.
• TissueTech, Inc.
   

Amniotic Membrane Industry News

•    In February 2022, Amnio Technology launched two new products - Dual Layer PalinGen X-Membrane and PalinGen Dual-Layer Membrane, both part of its PalinGen line for minimal manipulation and homologous use.
   
•    In December 2023, clinical-stage biopharma firm NovaBay Pharmaceuticals partnered with Woo University for supporting the education of eyecare professionals on using amniotic membranes.
   

Amniotic membrane market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product

• Cryopreserved
• Lyophilized

Market, By Application

• Surgical wounds
• Ophthalmology
• Stem cell biology
• Regenerative medicine
• Prenatal diagnosis
• Other applications

Market, By End-use

• Hospitals
• Ambulatory surgical centers (ASCs)
• Specialty clinics
• Research and academic institutes
• Other end-users      

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa